You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
安圖生物(603658.SH):安圖實業作為控股股東沒有減持計劃
格隆匯 09-19 15:44

格隆匯9月19日丨有投資者向安圖生物(603658.SH)提問:請問苗總海外市場今年上半年接近翻倍增長,下半年增速還會加速增長嗎,半年報顯示儀器收入同比去年上半年少了約1億收入,請問是什麼情況?下半年有什麼解決方案嗎?新冠庫存計提完畢了嗎?股東減持還會繼續?謝謝。

安圖生物回覆:尊敬的投資者您好,感謝您對公司的關注。預計下半年海外市場能保持高速增長;上半年儀器收入減少主要是受全自動分子檢測儀器銷售大幅下降影響,由於市場現狀,全自動分子儀器銷售暫時沒有較好的解決方案;新冠庫存已基本計提完畢;安圖實業作為控股股東沒有減持計劃。謝謝。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account